Opaleye Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-105,000
Closed -$7.7M 57
2019
Q1
$7.7M Buy
+105,000
New +$7.7M 2.13% 19